Sernova Biotherapeutics Inc
SEOVF
$0.1219
$0.00141.16%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.45M | 834.40K | 4.31M | 3.63M | 6.17M |
| Total Receivables | 313.30K | 257.90K | 213.90K | 360.10K | 892.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 347.70K | 336.80K | 114.20K | 514.70K | 487.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.11M | 1.43M | 4.64M | 4.51M | 7.55M |
|
|
|||||
| Total Current Assets | 2.11M | 1.43M | 4.64M | 4.51M | 7.55M |
| Net Property, Plant & Equipment | 534.50K | 543.30K | 598.40K | 649.90K | 691.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 0.00 | 77.20K | 157.70K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 162.00K | 154.70K | 160.60K | 162.10K | 162.90K |
| Total Assets | 2.80M | 2.13M | 5.40M | 5.40M | 8.56M |
|
|
|||||
| Total Accounts Payable | 13.72M | 13.72M | 12.37M | 13.67M | 11.58M |
| Total Accrued Expenses | 610.40K | 415.30K | 1.92M | 380.30K | 533.90K |
| Short-term Debt | 2.47M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 80.40K | 73.40K | 72.80K | 70.10K | 67.30K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.87M | 14.21M | 14.36M | 14.12M | 12.19M |
|
|
|||||
| Total Current Liabilities | 16.87M | 14.21M | 14.36M | 14.12M | 12.19M |
| Long-Term Debt | 583.90K | -- | -- | -- | -- |
| Short-term Debt | 2.47M | -- | -- | -- | -- |
| Capital Leases | 296.90K | 304.20K | 336.20K | 358.60K | 379.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.76M | 14.51M | 14.70M | 14.48M | 12.56M |
|
|
|||||
| Common Stock & APIC | 100.39M | 95.41M | 98.58M | 96.17M | 96.30M |
| Retained Earnings | -115.67M | -107.82M | -107.90M | -105.25M | -100.30M |
| Treasury Stock & Other | 329.10K | 23.80K | 24.70K | -- | -- |
| Total Common Equity | -14.95M | -12.39M | -9.30M | -9.08M | -4.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.95M | -12.39M | -9.30M | -9.08M | -4.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.95M | -12.39M | -9.30M | -9.08M | -4.00M |
|
|
|||||